AUTHOR=Yang Yang , Su Yi , Wei Guiming , Kang Zhewei , Lu Zhe , Liao Yundan , Lu Tianlan , Yan Hao , Yue Weihua , Qin Ying , Zhang Yuyanan 

TITLE=Association of NKAPL rs1635 With Cognitive Function in Early-Onset Schizophrenia

JOURNAL=Frontiers in Genetics

VOLUME=13

YEAR=2022

URL=https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2022.941171

DOI=10.3389/fgene.2022.941171

ISSN=1664-8021

ABSTRACT=<p><bold>BACKGROUND:</bold> Schizophrenia is a severe mental disorder with high heritability, and cognitive dysfunction is one of the core features. Growing evidence suggests the genetic risk of schizophrenia may contribute to cognitive impairments. The variant rs1635 (nucleotide sequence: c.455C&gt;A; amino acid sequence: T152N) located on the (NFKB activating protein like) <italic>NKAPL</italic> gene confers risk for schizophrenia and might play a role in the neurodevelopmental process, which is particularly relevant to cognitive function. However, the relationship between rs1635 and cognitive function remains unclear.</p><p><bold>METHODS:</bold> A total of 130 patients with early-onset schizophrenia (EOS) and 300 patients with adult-onset schizophrenia (AOS) of Han Chinese were recruited and underwent neurocognitive tests by using the MATRICS Consensus Cognitive Battery (MCCB). The <italic>NKAPL</italic> rs1635 was genotyped by using DNA sequencing. The peripheral blood NKAPL mRNA expression level was examined in 152T or 152N carriers (<italic>n</italic> = 20) in EOS patients, by using the qRT-PCR. The phosphorylation level of NAKPL T152N polymorphism was detected by cell experiments. In utero electroporation of mouse embryos was examined to explore the effect of Nkapl on neuronal migration.</p><p><bold>RESULTS:</bold> Compared with rs1635 AA and AC carriers, CC (the CC genotype encodes the protein NKAPL-152T) carriers of EOS patients performed better in cognitive domain of speed of processing (<italic>t</italic> = 2.644, <italic>p</italic> = 0.009), trail making test (<italic>t</italic> = 2.221, <italic>p</italic> = 0.028) and category fluency (<italic>t</italic> = 2.578, <italic>p</italic> = 0.011). However, patients with AOS exhibited no significant differences in seven domains among the three genotype groups. There were no significant differences in cognitive performance between EOS and AOS. In EOS patients, <italic>NKAPL</italic> mRNA level in NKAPL-152N carriers is significantly lower than that of NKAPL-152T carriers. The phosphorylation level of NKAPL-152N is significantly decreased compared to NKAPL-152T. In utero electroporation showed that <italic>Nkapl</italic> deletion impairs the embryonic radial migration process.</p><p><bold>CONCLUSION:</bold> The present study found that <italic>NKAPL</italic> rs1635 was associated with cognitive impairments and peripheral blood mRNA expression level in EOS patients. The NKAPL full-length protein is required for embryonic cortical neuronal migration. The phosphorylation level of NKAPL-152N is significantly decreased. The NKAPL T152N may affect the NAKPL mRNA expression level and embryonic cortical neuronal migration by regulating the NAKPL protein phosphorylation. These data suggest that <italic>NKAPL</italic> rs1635 affects cognitive function by regulating early brain development in early-onset schizophrenia.</p>